|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Rossi S, Fornari F and Buscarini L:
Percutaneous ultrasound-guided radiofrequency electrocautery for
the treatment of small hepatocellular carcinoma. J Interv Radiol.
8:97–103. 1993.
|
|
3
|
Bruix J and Sherman M: Practice Guidelines
Committee, American Association for the Study of liver diseases:
Management of hepatocellular carcinoma. Hepatology. 42:1208–1236.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kudo M, Izumi N, Kokudo N, Matsui O,
Sakamoto M, Nakashima O, Kojiro M and Makuuchi M: HCC Expert Panel
of Japan Society of Hepatology: Management of hepatocellular
carcinoma in Japan: Consensus-Based Clinical Practice Guidelines
proposed by the Japan Society of Hepatology (JSH) 2010 updated
version. Dig Dis. 29:339–364. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Livraghi T: Treatment of hepatocellular
carcinoma by interventional methods. Eur Radiol. 11:2207–2219.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Rhim H, Lim HK and Choi D: Current status
of radiofrequency ablation of hepatocellular carcinoma. World J
Gastrointest Surg. 2:128–136. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Livraghi T, Mäkisalo H and Line PD:
Treatment options in hepatocellular carcinoma today. Scand J Surg.
100:22–29. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Rossi S, Di Stasi M, Buscarini E, Quaretti
P, Garbagnati F, Squassante L, Paties CT, Silverman DE and
Buscarini L: Percutaneous RF interstitial thermal ablation in the
treatment of hepatic cancer. AJR Am J Roentgenol. 167:759–768.
1996. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Livraghi T, Goldberg SN, Lazzaroni S,
Meloni F, Solbiati L and Gazelle GS: Small hepatocellular
carcinoma: Treatment with radio-frequency ablation versus ethanol
injection. Radiology. 210:655–661. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kindberg GM, Tolleshaug H, Roos N and
Skotland T: Hepatic clearance of Sonazoid perfluorobutane
microbubbles by Kupffer cells does not reduce the ability of liver
to phagocytose or degrade albumin microspheres. Cell Tissue Res.
312:49–54. 2003.PubMed/NCBI
|
|
11
|
Guglielmi A, Ruzzenente A, Battocchia A,
Tonon A, Fracastoro G and Cordiano C: Radiofrequency ablation of
hepatocellular carcinoma in cirrhotic patients.
Hepatogastroenterology. 50:480–484. 2003.PubMed/NCBI
|
|
12
|
Watanabe R, Matsumura M, Chen CJ, Kaneda Y
and Fujimaki M: Characterization of tumor imaging with
microbubble-based ultrasound contrast agent, sonazoid, in rabbit
liver. Biol Pharm Bull. 28:972–977. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Minami Y, Kudo M, Kawasaki T, Chung H,
Ogawa C, Inoue T, Sakaguchi Y, Sakamoto H and Shiozaki H:
Percutaneous ultrasound-guided radiofrequency ablation with
artificial pleural effusion for hepatocellular carcinoma in the
hepatic dome. J Gastroenterol. 38:1066–1070. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Minami Y, Kudo M, Kawasaki T, Chang H,
Ogawa C and Shiozaki H: Percutaneous radiofrequency ablation guided
by contrast enhanced harmonic sonography with artificial pleural
effusion for hepatocellular carcinoma in the hepatic dome. AJR Am J
Roentgenol. 182:1224–1226. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tateishi R, Shiina S, Teratani T, Obi S,
Sato S, Koike Y, Fujishima T, Yoshida H, Kawabe T and Omata M:
Percutaneous radiofrequency ablation for hepatocellular carcinoma.
An analysis of 1000 cases. Cancer. 103:1201–1209. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lencioni RA, Allgaier HP, Cioni D,
Olschewski M, Deibert P, Crocetti L, Frings H, Laubenberger J,
Zuber I, Blum HE and Bartolozzi C: Small hepatocellular carcinoma
in cirrhosis: Randomized comparison of radio-frequency thermal
ablation versus percutaneous ethanol injection. Radiology.
228:235–240. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Rossi S, Fornari F, Paties C and Buscarini
L: Thermal lesions induced by 480 KHz localized current field in
guinea pig and pig livers. Tumori. 76:54–57. 1990.PubMed/NCBI
|
|
18
|
European Association For The Study Of The
Liver1, ; European Organisation For Research And Treatment Of
Cancer, . EASL-EORTC clinical practice guidelines: Management of
hepatocellular carcinoma. J Hepatol. 56:908–943. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Shiina S, Teratani T, Obi S, Sato S,
Tateishi R, Fujishima T, Ishikawa T, Koike Y, Yoshida H, Kawabe T
and Omata M: A randomized controlled trial of radiofrequency
ablation with ethanol injection for small hepatocellular carcinoma.
Gastroenterology. 129:122–130. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Pulvirenti A, Garbagnati F, Regalia E,
Coppa J, Marchiano A, Romito R, Schiavo M, Fabbri A, Burgoa L and
Mazzaferro V: Experience with radiofrequency ablation of small
hepatocellular carcinomas before liver transplantation. Transplant
Proc. 33:pp. 1516–1517. 2001; View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Harrison LE, Koneru B, Baramipour P,
Fisher A, Barone A, Wilson D, Torre A Dela, Cho KC, Contractor D
and Korogodsky M: Locoregional recurrences are frequent after
radiofrequency ablation for hepatocellular carcinoma. J Am Coll
Surg. 197:759–764. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hirooka M, Ochi H, Koizumi Y, Tokumoto Y,
Hiraoka A, Kumagi T, Abe M, Tanaka H and Hiasa Y: Local recurrence
of hepatocellular carcinoma in the tumor blood drainage area
following radiofrequency ablation. Mol Clin Oncol. 2:182–186.
2014.PubMed/NCBI
|
|
23
|
Kudo M: Diagnostic imaging of
hepatocellular carcinoma: Recent progress. Oncology. 81 Suppl
1:S73–S85. 2011. View Article : Google Scholar
|
|
24
|
Mita K, Kim SR, Kudo M, Imoto S, Nakajima
T, Ando K, Fukuda K, Matsuoka T, Maekawa Y and Hayashi Y:
Diagnostic sensitivity of imaging modalities for hepatocellular
carcinoma smaller than 2 cm. World J Gastroenterol. 16:4187–4192.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Masuzaki R, Shiina S, Tateishi R, Yoshida
H, Goto E, Sugioka Y, Kondo Y, Goto T, Ikeda H, Omata M and Koike
K: Utility of contrast-enhanced ultrasonography with Sonazoid in
radiofrequency ablation for hepatocellular carcinoma. J
Gastroenterol Hepatol. 26:759–764. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Makino Y, Imai Y, Igura T, Kogita S, Sawai
Y, Fukuda K, Hori M, Kudo M and Murakami T: Usefulness of the
extracted-overlay function in CT/MR-ultrasonography fusion imaging
for radiofrequency ablation of hepatocellular carcinoma. Dig Dis.
31:485–489. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Koda M, Ueki M, Maeda Y, Mimura K, Okamoto
K, Matsunaga Y, Kawakami M, Hosho K and Murawaki Y: Percutaneous
sonographicially guided radiofrequency ablation with artificial
pleural effusion for hepatocellular carcinoma located under the
diaphragm. AJR Am J Roentgenol. 183:583–588. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Fukuno H, Tamaki K, Urata M, Kohno N,
Shimizu I, Nomura M, Ito S and Saito K: Influence of an artificial
pleural effusion technique on cardio-pulmonary function and
autonomic activity. J Med Invest. 54:48–53. 2007. View Article : Google Scholar : PubMed/NCBI
|
